| Dr Veeresh Anand Medlery, MD | |
|
2609 Medical Office Pl, Goldsboro, NC 27534-9428 | |
| (989) 681-3524 | |
| Not Available |
| Full Name | Dr Veeresh Anand Medlery |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2609 Medical Office Pl, Goldsboro, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437356565 | NPI | - | NPPES |
| 0802911812 | Other | MI | BCBSM |
| 01012411 | Other | MI | HEALTHPLUS COMMERCIAL |
| 1032406 | Other | MI | MCLAREN |
| 200000017757 | Other | MI | PHP COMMERCIAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301083520 (Michigan) | Primary |
| Entity Name | Eastern Medical Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194762807 PECOS PAC ID: 3173414109 Enrollment ID: O20040322000237 |
News Archive
Since USAID launched 50 years ago, the agency "has had a rich history of supporting global health, including research and development (R&D)," Global Health Technologies Coalition (GHTC) Director Kaitlin Christenson writes in the organization's "Breakthroughs" blog.
After people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. But the reason has long puzzled scientists. Now researchers at Joslin Diabetes Center have identified the misstep that sparks this runaway chronic damage and a promising way to block it.
Pharmacyclics, Inc. today announced the signing of a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765, a first-in-class, small molecule inhibitor of Bruton's tyrosine kinase (Btk) for the treatment of hematologic malignancies.
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand's aggressive war on illicit drugs and the war's impact on injection drug users.
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Veeresh Anand Medlery, MD 2609 Medical Office Pl, Goldsboro, NC 27534-9428 Ph: (989) 681-3524 | Dr Veeresh Anand Medlery, MD 2609 Medical Office Pl, Goldsboro, NC 27534-9428 Ph: (989) 681-3524 |
News Archive
Since USAID launched 50 years ago, the agency "has had a rich history of supporting global health, including research and development (R&D)," Global Health Technologies Coalition (GHTC) Director Kaitlin Christenson writes in the organization's "Breakthroughs" blog.
After people with type 1 diabetes have a heart attack, their long-term chance of suffering even more heart damage skyrockets. But the reason has long puzzled scientists. Now researchers at Joslin Diabetes Center have identified the misstep that sparks this runaway chronic damage and a promising way to block it.
Pharmacyclics, Inc. today announced the signing of a five-year Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765, a first-in-class, small molecule inhibitor of Bruton's tyrosine kinase (Btk) for the treatment of hematologic malignancies.
Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand's aggressive war on illicit drugs and the war's impact on injection drug users.
Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.
› Verified 7 days ago
Bruce W. Rogers, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 W Ash St, Ste 202, Goldsboro, NC 27530 Phone: 919-731-4941 Fax: 919-731-2416 | |
Ryan Scott King, Family Medicine Medicare: Medicare Enrolled Practice Location: 208 Cox Blvd Ste 102, Goldsboro, NC 27534 Phone: 919-731-6018 | |
Mark Ashford Blizzard, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 2704 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-736-4724 | |
Reena Sini Joseph, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 2701 Medical Office Pl, Goldsboro, NC 27534 Phone: 919-739-8680 Fax: 919-739-8616 | |
Saskia Rupnarain, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2600 Us Highway 70 W, Goldsboro, NC 27530 Phone: 919-739-4808 Fax: 919-739-4810 | |
James Chang, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1401 W Ash St, Goldsboro, NC 27530 Phone: 919-947-8183 | |
Dr. Phillip Walker Moye, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Wayne Memorial Dr, Emergency Dept, Goldsboro, NC 27534 Phone: 919-731-6060 Fax: 919-580-9224 |